Huiyun Ni

Low expression of miRNA-224 predicts poor clinical outcome in diffuse large B-cell lymphoma treated with R-CHOP

Xin-feng Wang, G. Song, Fuliang Tian, 2015, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

MicroRNAs in diffuse large B-cell lymphoma.

W. Cho, Huiyun Ni, L. Zou, 2016, Oncology letters.

Expression of CD40 is a positive prognostic factor of diffuse large B-cell lymphoma treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone)

Shukui Wang, W. Cho, W. C. Cho, 2016, OncoTargets and therapy.

Deregulated expression of miR-224 and its target gene: CD59 predicts outcome of diffuse large B-cell lymphoma patients treated with R-CHOP.

Yu-qin Pan, Bangshun He, L. Gu, 2014, Current cancer drug targets.

Expression of CD40 is a positive prognostic factor of diffuse large B-cell lymphoma treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone).

Shukui Wang, W. C. Cho, Fuliang Tian, 2016 .